Brivaracetam Tablet, Film Coated
Product Images NDC 72205-271

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Brivaracetam (NDC 72205-271). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novadoz Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Brivaracetam-100mg-100s-blister-carton-label (Brivaracetam 100mg 100s Blister Carton Label)

This is a medication label for Novadoz® containing Brivaracetam tablets in a package of 100 blisters, with each blister containing one tablet. The label also includes storage instructions, manufacturer details, and a reminder to keep the medication out of reach of children. The medication guide is advised to be dispensed to each patient by the pharmacist.*

FDA Label Image

Brivaracetam-100mg-1s-blister-foil-label (Brivaracetam 100mg 1s Blister Foil Label)

This is a product label for Levetiracetam tablets distributed by Novadoz Pharmaceuticals LLC. The tablets are made in India and the batch number is shown as XXXXXXXX. The expiration date format is YYYY-MM. The label also contains a unique identification code RxOnTy Nbc72'21)5271101 for the product.*

FDA Label Image

Brivaracetam-100mg-60s-container-label (Brivaracetam 100mg 60s Container Label)

This is a prescription drug called Brivaracetam® available in tablet form. Each film-coated tablet contains 100 mg of Brivaracetam. The usual dosage instructions can be found in the accompanying package insert. It is recommended to store the tablets at 20° to 25°C (68° to 77°F) with excursions permitted between 15° to 30°C (59° to 86°F). The medication is manufactured by MSN Laboratories Private Limited in Telangana, India and distributed by Novadoz Pharmaceuticals LLC in Piscataway, NJ. Additionally, it is advised to dispense the accompanying Medication Guide to each patient with the prescription.*

FDA Label Image

Brivaracetam-10mg-60s-container-label (Brivaracetam 10mg 60s Container Label)

This is a description of a medication called Brivaracetam. Each film-coated tablet contains 10 mg of the active ingredient. The usual dosage information can be found in the accompanying package insert. It is recommended to store the tablets at a temperature between 20°C to 25°C, with excursions permitted between 15°C to 30°C. The medication is manufactured by MSN Laboratories Private Limited in India and distributed by Novadoz Pharmaceuticals LLC in the United States. The package contains a total of 60 tablets. It is a prescription medication and a Medication Guide is provided to each patient by the pharmacist.*

FDA Label Image

Brivaracetam-25mg-100s-blister-carton-label (Brivaracetam 25mg 100s Blister Carton Label)

FDA Label Image

Brivaracetam-25mg-1s-blister-foil-label (Brivaracetam 25mg 1s Blister Foil Label)

This is a label from Novadoz Pharmaceuticals LLC for Brivaracetam tablets manufactured in India with an expiration date of 11/2025. The lot number and expiration date are XXXXXXXXX and YYYY-MM respectively. The tablets are intended for distribution and the product code is 72205 26801.*

FDA Label Image

Brivaracetam-25mg-60s-container-label (Brivaracetam 25mg 60s Container Label)

Each film-coated tablet contains 25 mg brivaracetam. The usual dosage can be found in the accompanying package insert. Store the tablets at 20° to 25°C (68° to 77°F) with excursions permitted between 15° to 30°C (59° to 86°F) as per USP Controlled Room Temperature guidelines. This medication is manufactured by MSN Laboratories Private Limited in Telangana, India, and distributed by Novadoz Pharmaceuticals LLC. For full prescribing information, refer to the Medication Guide given to each patient.*

FDA Label Image

Brivaracetam-50mg-100s-blister-carton-label (Brivaracetam 50mg 100s Blister Carton Label)

This text describes Brivaracetam Tablets, which come in a unit dose package of 100 tablets, with each blister containing 1 tablet. It includes storage instructions, dosage information, NDC numbers for prescription use, and a reminder to dispense the Medication Guide to each patient. The tablets are distributed by Novadoz Pharmaceuticals LLC and are indicated for prescription use only.*

FDA Label Image

Brivaracetam-50mg-1s-blister-foil-label (Brivaracetam 50mg 1s Blister Foil Label)

This text contains information related to a medication called Brivaracetam distributed by Novadoz Pharmaceuticals LLC. The product is made in India, with the indicated issue date of November 2025. It involves a lot number and an expiration date, which are not fully displayed due to errors.*

FDA Label Image

Brivaracetam-50mg-60s-container-label (Brivaracetam 50mg 60s Container Label)

Each film-coated tablet contains 50 mg brivaracetam. The usual dosage can be found in the accompanying package insert. Brivaracetam should be stored at 20° to 25°C (66° to 77°F) with excursions permitted between 15° to 30°C (59° to 86°F). The medication is manufactured by MSN Laboratories Private Limited in Telangana, India, and distributed by Novadoz Pharmaceuticals LLC in Piscataway, NJ. Pharmacies should dispense the accompanying Medication Guide with each prescription to patients.*

FDA Label Image

Brivaracetam-75mg-60s-container-label (Brivaracetam 75mg 60s Container Label)

Each film-coated tablet of Brivaracetam contains 75 mg of the active ingredient. Brivaracetam is a prescription medication that should be stored between 20°C to 25°C (68°F to 77°F). The standard dosage information can be found in the accompanying insert. This medication is manufactured by MSN Laboratories Private Limited in Telangana, India, and distributed by Novadoz Pharmaceuticals LLC. It is essential for pharmacists to dispense the medication guide to each patient along with the tablets.*

FDA Label Image

Brivaracetam-figure-1 (Brivaracetam Figure 1)

This text contains information about the reduction in seizure frequency from baseline for different dosages of Brivaracetam and placebo in a study involving a specific number of patients for each group. The data represents the proportion of patients in each category of reduction in seizure frequency.*

FDA Label Image

Brivaracetam-structure (Brivaracetam Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.